General Information of Drug (ID: DMJ18YL)

Drug Name
Secnidazole Drug Info
Synonyms
3366-95-8; Secnidazol; Secnidazolum; Flagentyl; Secnidazolum [INN-Latin]; Solosec; RP 14539; Secnidazol [INN-Spanish]; PM 185184;Secnidazole (Flagentyl); SYM-1219; EINECS 222-134-0; seknidazol; MLS000559043; PM-185184; NCGC00095158-01; SMR000149359; RP-14539
Indication
Disease Entry ICD 11 Status REF
Amoebiasis 1A36 Approved [1]
Bacterial vaginosis MF3A Approved [2]
Cross-matching ID
PubChem CID
71815
ChEBI ID
CHEBI:94433
CAS Number
CAS 3366-95-8
TTD Drug ID
DMJ18YL
INTEDE Drug ID
DR2431
ACDINA Drug ID
D01418

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Drug(s) Metabolized By Nitroreductase (NTR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Metronidazole DMTIVEN Abscess Approved [3]
Tindamax DM3OWT4 Bacterial infection 1A00-1C4Z Approved [3]
AI3-23606 DMHMT49 N. A. N. A. Phase 1 [3]
BENZOQUINONE DMNBA0G Discovery agent N.A. Investigative [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Nitroreductase (NTR) Main DME DEAN5EW NFSB_ENTCL Substrate [3]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
3 Overexpression, isotopic labeling, and spectral characterization of Enterobacter cloacae nitroreductase. Protein Expr Purif. 1998 Jun;13(1):53-60.